ACOUSORT AB
Desconocido
EVEREST: Extracellular Vesicle Research Exchanges for Advanced Biomarkers and Therapeutics
The EVEREST project is a pioneering consortium in Extracellular Vesicle (EVs) research, bringing together 22 institutions from 11 countries,...
2024-08-01 - 2028-12-31 | Financiado
2024-08-01 - 2028-12-31 | Financiado
AcouSome: Acoustofluidic thin-film actuated chip for exosome separation from blood
ACOUSORT AB
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2022-TRANSITION-01
AcouSome is a consortium stemming from the ongoing EIC-FET Open BioWings project, and consists of four of the BioWings project
partners (Aco...
2022-11-11 - 2025-12-31 | Financiado
2022-11-11 - 2025-12-31 | Financiado
ACOUPLASMA: Market maturation of a blood plasma separation module enabling plasma based diagnostic point of care...
ACOUSORT AB
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
AcouSort has developed a technological platform based on acoustic forces to separate, enrich and wash cells and other particles. This techni...
2018-11-26 - 2019-02-28 | Financiado
2018-11-26 - 2019-02-28 | Financiado
BioWings: Bio compatible electrostrictive smart materials for future generation of medical micro electro mech...
ACOUSORT AB
participó en un
H2020:
H2020-FETOPEN-2016-2017
Demographic trends, such as the rapid growth and ageing of the world population, are putting pressure on global healthcare systems, increasi...
2018-05-03 - 2022-11-30 | Financiado
2018-05-03 - 2022-11-30 | Financiado
* No se disponen de datos de la empresa actual.